Skip to Content

Epidermolysis Bullosa

(Inherited Epidermolysis Bullosa)


Daniel M. Peraza

, MD, Geisel School of Medicine at Dartmouth University

Last full review/revision Sep 2020| Content last modified Sep 2020

Epidermolysis bullosa is a group of 4 very rare genetic diseases and their subtypes. Epithelial fragility and easy blistering of skin and mucous membranes usually manifest at birth or in infancy. Disease phenotypes vary from mild to life-threatening. Diagnosis is by skin biopsy with immunofluorescence testing or transmission electron microscopy, and gene analysis. Treatment is supportive, and specialized multidisciplinary participation is required for severe cases.

Epidermolysis bullosa occurs in 20/million live births. There is no gender predilection. Occasionally, epidermolysis bullosa is not recognized until adolescence or early adulthood.

Epidermolysis bullosa is a group of inherited disorders that involve various genetic mutations. This group of disorders is distinct from epidermolysis bullosa acquisita, which is thought to be an autoimmune disease.

Pathophysiology of Epidermolysis Bullosa

Genetically mediated defects in epithelial adhesion proteins result in skin and mucous membrane fragility, which predisposes the epithelium to easy bullae formation after minor trauma or sometimes spontaneously.

Types of epidermolysis bullosa

Four major epidermolysis bullosa types are defined, based on the level or levels of tissue cleavage and bullae formation (see figure Skin cleavage levels in epidermolysis bullosa) in relation to the skin’s basement membrane zone (dermal–epidermal junction):

  • Epidermolysis bullosa simplex: Epidermis
  • Junctional epidermolysis bullosa: Lamina lucida of the basement membrane zone
  • Dystrophic epidermolysis bullosa: Sublamina densa (uppermost dermis, just below the lamina densa of the basement membrane zone)
  • Kindler syndrome: Variable—intraepidermal or subepidermal

Skin cleavage levels in epidermolysis bullosa

In this figure, the basement membrane zone is disproportionately enlarged to display its layers. Epidermolysis bullosa (EB) simplex blisters form in the levels of the epidermis. Junctional EB blisters form in the lamina lucida. Dystrophic EB blisters form in the sublamina densa (uppermost dermis). Kindler syndrome blisters can form in the intraepidermal or subepidermal level.

Skin cleavage levels in epidermolysis bullosa

Different types have different inheritance patterns. (See table Some Features of the Major Epidermolysis Bullosa Types.)

Epidermolysis bullosa simplex is the most common and mildest type, occurring in about 80% of cases.

Multiple subtypes are defined, based on features such as

  • Distribution of lesions (localized vs generalized)
  • Relative cutaneous vs extracutaneous severity
  • Other skin findings (eg, exuberant granulation tissue, mottled pigmentation, pseudosyndactyly [fusion of skin between digits])
  • Mode of inheritance (autosomal dominant vs autosomal recessive)
  • Specific genes involved

(See table Some Features of the Major Epidermolysis Bullosa Types.)

Some Features of the Major Epidermolysis Bullosa Types


Mode of Inheritance

Skin Cleavage Level

Characteristic Mutated Genes

Epidermolysis bullosa simplex

Autosomal dominant

Rarely autosomal recessive



Junctional epidermolysis bullosa

Autosomal recessive

Lamina lucida of the basement membrane zone

LAMB3, COL17A1, LAMC2, and LAMA3

Dystrophic epidermolysis bullosa

Autosomal dominant/autosomal recessive

Sublamina densa (uppermost dermis, just below the lamina densa of the basement membrane zone)


Kindler syndrome

Autosomal recessive

Variable—intraepidermal or subepidermal


Symptoms and Signs of Epidermolysis Bullosa

All types of epidermolysis bullosa manifest with painful, inappropriate blistering. Severity of symptoms correlates to severity of blistering and scarring and ranges from mild to severe.

Extensive mucocutaneous epidermolysis bullosa of any type can cause severe pain. Widespread skin lesions cause fluid imbalances and protein wasting. Skin lesions may become infected, and infections can become systemic. Mucous membrane involvement may cause malnutrition and failure to thrive, impaired breathing, and genitourinary problems.

Epidermolysis bullosa simplex

A mild subtype causes local blistering of only the palms and soles.

A severe, generalized subtype causes blistering of the trunk, arms, and neck, and the oral mucosa may be involved.

Bullae usually heal without scarring because they lie superficially in the epidermis. Over time, hyperkeratosis develops on the palms and soles, either as focal calluses or as diffuse thickening in severe cases.

Junctional epidermolysis bullosa

A mild subtype affects only the elbows, hands, knees, and feet (typical friction sites) and often abates after infancy. Enamel hypoplasia, nail malformations, and alopecia also occur. Healing does not involve extensive scarring.

A severe, generalized mucocutaneous blistering may involve large areas of skin and also the conjunctiva, mouth, and gastrointestinal, respiratory, and genitourinary tracts.

Characteristic red, moist skin plaques (healing by granulation tissue formation) around the mouth and central face are pathognomonic.

Severe bullae heal with scarring because they occur in deeper junctional and dermal levels. Scarring of luminal lesions may cause symptomatic strictures. For example, laryngotracheal stenosis can cause stridor or a weak or hoarse cry, which implies internal involvement and a poor prognosis. Scarring of skin lesions can result in joint contractures and pseudosyndactyly.

Dystrophic epidermolysis bullosa

Mild and moderate subtypes primarily affect only the elbows, hands, knees, and feet. Nail malformations often occur and may be the sole symptom in mild cases.

A severe subtype manifests with diffuse mucocutaneous blistering at birth. The entire skin surface and the oral and gastrointestinal mucosa may be affected. Often, wide areas of skin are absent, sloughed during birth. Scarring causes a variety of external and internal complications. Pseudosyndactyly occurs nearly always.

Mild bullae heal with nonsevere scarring (worse in the moderate form) and milia. Severe bullae heal with scarring because they occur in deeper levels.

Kindler syndrome

Kindler syndrome has no subtypes.

Blistering particularly affects the dorsa of the hands and feet. Repeated episodes lead to progressive skin atrophy (thin, wrinkled skin), which can spread to other areas.

Photosensitivity, which may be mild, distinguishes Kindler syndrome from the other 3 major epidermolysis bullosa types.

Poikiloderma (constellation of skin atrophy, pigment changes, and telangiectasias) is common.

Mucocutaneous scarring leads to esophageal and genitourinary stenoses, ectropion, and pseudosyndactyly. Severe Kindler syndrome bullae heal with scarring because they occur in deeper levels.

Diagnosis of Epidermolysis Bullosa

  • Biopsy and immunofluorescence testing or transmission electron microscopy of skin
  • Gene mutation analysis

Epidermolysis bullosa is suspected based on clinical presentation. Family history may indicate the mode of inheritance and thus the possible type: autosomal dominant inheritance (epidermolysis bullosa simplex, dystrophic epidermolysis bullosa) or autosomal recessive inheritance (junctional epidermolysis bullosa, dystrophic epidermolysis bullosa, Kindler syndrome, rarely epidermolysis bullosa simplex).

Differential diagnosis includes common friction blisters and epidermolysis bullosa acquisita.

Diagnosis of specific types and subtypes is based on family history, biopsy and immunofluorescence testing or transmission electron microscopy of a freshly induced blister (not from the palms or soles), and gene mutation analysis of a blood sample.

Immunofluorescence testing or transmission electron microscopy determines the level of cleavage and bullae formation.

Genetic testing is usually done to confirm specific disease type and guide genetic counseling. (See table Some Features of the Major Epidermolysis Bullosa Types.)

Possible prenatal testing should be discussed with families that have a history of epidermolysis bullosa.

Prognosis for Epidermolysis Bullosa

Severe junctional epidermolysis bullosa and dystrophic epidermolysis bullosa cause significant mortality before age 2 years. Generalized severe epidermolysis bullosa also can be fatal. Death occurs after complications such as infection, malnutrition, and dehydration.

Blistering tends to lessen with age.

Patients with junctional epidermolysis bullosa, dystrophic epidermolysis bullosa, and Kindler syndrome may develop squamous cell carcinomas of skin and mucosal membranes in adulthood.

Chronic disease can be debilitating and life-altering. However, some serious symptoms can lessen over time as somatic growth re-expands internal lumina that were stenosed by previous scarring.

Treatment of Epidermolysis Bullosa

  • Avoidance of friction and trauma to skin and mucous membranes
  • Treatment to promote healing of blister sites
  • Prevention and treatment of complications

(See also Wound International's best practice guidelines for skin and wound care in epidermolysis bullosa.)

Treatment of epidermolysis bullosa is symptomatic; multidisciplinary specialization may likely be needed for both severe and chronic disease (1).

Any and all means of reducing skin friction are used. Neonates and infants are handled with exquisite gentleness. Soft clothing, padded furniture, and cool ambient temperatures help reduce blister formation.

A soft diet and stool softeners may be helpful if the gastrointestinal tract is affected.

Bullae should be properly incised and dressed, as instructed by a wound care specialist, to prevent further skin damage and infection. Minimally adherent dressings and tapes may be used; often, bandages covered with petroleum jelly are held in place with a light gauze wrap.

Drugs are given as needed for pain, itching, and infection.

Surgical treatment may include gastrostomy tube placement, esophageal dilation, and correction of pseudosyndactyly and contractures.

Treatment reference

  • 1. El Hachem M, Zambruno G, Bourdon-Lanoy E, et al: Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis 9:76, 2014. doi: 10.1186/1750-1172-9-76

More Information

The following is an English-language resource that may be useful. Please note that THE MANUAL is not responsible for the content of this resource.

  • Wound International: Best practice guidelines for skin and wound care in epidermolysis bullosa

Copyright © 2022 Merck & Co., Inc., known as MSD outside of the US, Kenilworth, New Jersey, USA. All rights reserved. Merck Manual Disclaimer